Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Long-Term Prognostic Factors in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A 15-Year Multicenter Retrospective Study
by
Zhang, You-Yan
, Wang, Hui-Juan
, Qin, Dong
, Zhang, Wei
, Song, Hai-Xia
, Yang, Zhe
, Li, Zhuo-Jun
, Guo, Lin-Zheng
, Mo, Yan-Ju
, Wu, Juan
, Zhou, Meng-Meng
, Wang, Chun-Ying
, Li, Li-Mei
, Liao, Qian-Qian
, Xie, Zhou-Ni
, Chen, Peng
, Zhu, Ke-Wei
, Cong, Shan
, Cui, Xiao-Jiao
, Wei, Fang-Ning
, Ren, Ya-Fei
, Xu, Hong-Zhen
, Tang, Yan-Feng
, Shi, Yu-Hong
in
5-year survival rate
/ ANCA-associated vasculitis (AAV)
/ Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
/ Antibodies
/ Antibodies, Antineutrophil Cytoplasmic
/ Antineutrophil cytoplasmic antibodies
/ Antinuclear antibodies
/ Autoimmune diseases
/ C-reactive protein
/ Chronic illnesses
/ Clinical medicine
/ decision curve analysis (DCA)
/ Electronic medical records
/ Glomerular filtration rate
/ Granulomatosis
/ Granulomatosis with Polyangiitis
/ Humans
/ Immunology
/ Informed consent
/ Laboratories
/ Leukocytes (neutrophilic)
/ Lymphocytes
/ Medical ethics
/ Medical prognosis
/ Microscopic Polyangiitis
/ Mortality
/ Multivariate analysis
/ Myeloblastin
/ Neutrophils
/ nomogram
/ Nomograms
/ overall survival (OS)
/ Patients
/ Peroxidase
/ Prediction models
/ Prognosis
/ Proteinase 3
/ Renal function
/ Retrospective Studies
/ Statistical analysis
/ Vasculitis
2022
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Long-Term Prognostic Factors in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A 15-Year Multicenter Retrospective Study
by
Zhang, You-Yan
, Wang, Hui-Juan
, Qin, Dong
, Zhang, Wei
, Song, Hai-Xia
, Yang, Zhe
, Li, Zhuo-Jun
, Guo, Lin-Zheng
, Mo, Yan-Ju
, Wu, Juan
, Zhou, Meng-Meng
, Wang, Chun-Ying
, Li, Li-Mei
, Liao, Qian-Qian
, Xie, Zhou-Ni
, Chen, Peng
, Zhu, Ke-Wei
, Cong, Shan
, Cui, Xiao-Jiao
, Wei, Fang-Ning
, Ren, Ya-Fei
, Xu, Hong-Zhen
, Tang, Yan-Feng
, Shi, Yu-Hong
in
5-year survival rate
/ ANCA-associated vasculitis (AAV)
/ Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
/ Antibodies
/ Antibodies, Antineutrophil Cytoplasmic
/ Antineutrophil cytoplasmic antibodies
/ Antinuclear antibodies
/ Autoimmune diseases
/ C-reactive protein
/ Chronic illnesses
/ Clinical medicine
/ decision curve analysis (DCA)
/ Electronic medical records
/ Glomerular filtration rate
/ Granulomatosis
/ Granulomatosis with Polyangiitis
/ Humans
/ Immunology
/ Informed consent
/ Laboratories
/ Leukocytes (neutrophilic)
/ Lymphocytes
/ Medical ethics
/ Medical prognosis
/ Microscopic Polyangiitis
/ Mortality
/ Multivariate analysis
/ Myeloblastin
/ Neutrophils
/ nomogram
/ Nomograms
/ overall survival (OS)
/ Patients
/ Peroxidase
/ Prediction models
/ Prognosis
/ Proteinase 3
/ Renal function
/ Retrospective Studies
/ Statistical analysis
/ Vasculitis
2022
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Long-Term Prognostic Factors in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A 15-Year Multicenter Retrospective Study
by
Zhang, You-Yan
, Wang, Hui-Juan
, Qin, Dong
, Zhang, Wei
, Song, Hai-Xia
, Yang, Zhe
, Li, Zhuo-Jun
, Guo, Lin-Zheng
, Mo, Yan-Ju
, Wu, Juan
, Zhou, Meng-Meng
, Wang, Chun-Ying
, Li, Li-Mei
, Liao, Qian-Qian
, Xie, Zhou-Ni
, Chen, Peng
, Zhu, Ke-Wei
, Cong, Shan
, Cui, Xiao-Jiao
, Wei, Fang-Ning
, Ren, Ya-Fei
, Xu, Hong-Zhen
, Tang, Yan-Feng
, Shi, Yu-Hong
in
5-year survival rate
/ ANCA-associated vasculitis (AAV)
/ Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
/ Antibodies
/ Antibodies, Antineutrophil Cytoplasmic
/ Antineutrophil cytoplasmic antibodies
/ Antinuclear antibodies
/ Autoimmune diseases
/ C-reactive protein
/ Chronic illnesses
/ Clinical medicine
/ decision curve analysis (DCA)
/ Electronic medical records
/ Glomerular filtration rate
/ Granulomatosis
/ Granulomatosis with Polyangiitis
/ Humans
/ Immunology
/ Informed consent
/ Laboratories
/ Leukocytes (neutrophilic)
/ Lymphocytes
/ Medical ethics
/ Medical prognosis
/ Microscopic Polyangiitis
/ Mortality
/ Multivariate analysis
/ Myeloblastin
/ Neutrophils
/ nomogram
/ Nomograms
/ overall survival (OS)
/ Patients
/ Peroxidase
/ Prediction models
/ Prognosis
/ Proteinase 3
/ Renal function
/ Retrospective Studies
/ Statistical analysis
/ Vasculitis
2022
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Long-Term Prognostic Factors in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A 15-Year Multicenter Retrospective Study
Journal Article
Long-Term Prognostic Factors in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A 15-Year Multicenter Retrospective Study
2022
Request Book From Autostore
and Choose the Collection Method
Overview
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a multisystem autoimmune disease with small-vessel involvement. In AAV, microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) are major clinicopathologic variants. In addition, myeloperoxidase (MPO) and proteinase 3 (PR3) are major target antigens. The objective of the study was to explore the predictive factors for long-term survival in AAV patients.
A multicenter retrospective study was carried out on 407 patients between 2005 and 2020. Clinical parameters were obtained from laboratory tests including the ANCA types, antinuclear antibody (ANA), extractable nuclear antigen (ENA), anti-streptolysin O (ASO), glomerular filtration rate (GFR), and the laboratory examinations for the blood routine, liver function, renal function, and immunity, etc. The data for clinical parameters were collected from electronic medical records (EMRs), and the data for patient survival were acquired through regular follow-up. The association of clinical parameters with overall survival (OS) along with 3-year and 5-year survival rates was analyzed, and the nomogram as a predictive model was established according to the analysis results.
In the present study, 336 (82.6%) patients and 46 (11.3%) patients were diagnosed with MPA and GPA, respectively. The mean and median OS for all the patients were 2,285 and 2,290 days, respectively. The 1-year, 3-year, 5-year, and 10-year cumulative survival rates for all the patients were 84.2%, 76.3%, 57.2%, and 32.4%, respectively. Univariate and multivariate survival analyses indicated that the independent prognostic factors included age, pathological categories (MPA, GPA, and other types), serum ANCA types (negative or positive for MPO and/or PR3), ANA, ASO, GFR, lymphocyte, neutrophil-to-lymphocyte ratio (NLR), and C-reactive protein (CRP), and these clinical parameters except for ASO were used to construct a nomogram. The nomogram for 3-year and 5-year survival rates had a C-index of 0.721 (95% CI 0.676-0.766). The calibration curves showed that the predicted values of the nomogram for 3-year and 5-year survival rates were generally consistent with practical observed values, and decision curve analysis (DCA) further demonstrated the practicability and accuracy of the predictive model.
Laboratory tests at diagnosis have great significance in the prediction of long-term survival in AAV patients.
Publisher
Frontiers Media SA,Frontiers Media S.A
This website uses cookies to ensure you get the best experience on our website.